Evidence map›Paper›PMID 40496060›Full record

ArticleRespirology case reports2025

A Rare and Challenging Presentation of an Inflammatory Myofibroblastic Tumour: A Case Report.

Rohit Shirgaonkar, Srivatsa Lokeshwaran, Susmita Rakshit

Abstract read
In one paragraph

Article in Respirology case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Rohit ShirgaonkarDepartment of Interventional Pulmonology and Lung Transplant Aster Hospital Whitefield Bangalore India.ORCID https://orcid.org/0009-0002-5352-9701
Srivatsa LokeshwaranDepartment of Interventional Pulmonology and Lung Transplant Aster Hospital Whitefield Bangalore India.
Susmita RakshitDepartment of Pathology Aster Hospital Whitefield Bangalore India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inflammatory Myofibroblastic Tumours (IMTs) are rare pulmonary neoplasms, accounting for less than 1% of lung tumours. Patients present with non-specific symptoms and diverse radiological findings. A 32-year-old female presented with progressively worsening cough, haemoptysis, low-grade fever and increasing shortness of breath. Chest X-ray revealed a total right lung collapse. Further imaging revealed a mass obstructing the right mainstem bronchus. A staged debulking procedure using rigid bronchoscopy was performed, followed by the insertion of a silicone stent to maintain airway patency. Endobronchial growth turned out to be an Inflammatory Myofibroblastic tumour. The patient showed significant improvement in respiratory function and lung re-expansion. Adjuvant therapy with ALK inhibitor was initiated. IMTs, while benign histologically, may recur or metastasise, requiring long-term monitoring. Bronchoscopic interventions offer effective treatment for localised disease, while surgery is preferred for extensive tumours. Early diagnosis, genetic profiling and a multidisciplinary approach are key for optimal outcomes.

Indexed as

cryobiopsydebulkingInflammatory Myofibroblastic tumourrigid bronchoscopystent

Identifiers

PMID40496060
PMCPMC12149438

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.